NEURONES: 8.6% organic growth in 2024
Werte in diesem Artikel
PRESS INFORMATION
Heading: 2024 annual revenues Nanterre, February 12, 2025 (after trading)
8.6% organic growth in 2024
(being audited, in € millions) | 2023 | 2024 | Growth | of which organic |
Revenues | 741.2 | 810.4 | + 9.3% | + 8.6% |
Achievements
Forecasts for the year were exceeded, both in terms of activity and operating profit:
- revenues totaled €810.4 million, up 9.3% (with 8.1% growth in Q4 );
- operating profit represented 9.6% of revenues (€77.9 million *).
With double-digit growth, the Group's expansion is driven by digital projects, data, cybersecurity, public clouds, sovereign ans trusted clouds (SecNumCloud).
The Group’s net increase in the payroll of 340 by 2024 has been supplemented by greater use of subcontracting.
The full final annual results will be published on Wednesday, March 5, 2025 after the stock exchange closes.
Outlook
As usual, the forecasts for 2025 will be posted along with the Group's Q1 revenues.
* being audited.
About NEURONES
With 7,100 experts, and ranking among the French leaders in consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.
Euronext Paris (compartment B - NRO) – Euronext Tech Leaders – DSS mid-caps – ‘PEA-PME’ eligible
www.neurones.net
Press Relations: O'Connection Julia Philippe-Brutin Tel.: +33 (0)6 03 63 06 03 jpbrutin@oconnection.fr | NEURONES Matthieu Vautier Tel.: +33 (0)1 41 37 41 37 rp@neurones.net | Investor Relations: NEURONES Paul-César Bonnel Tel.: +33 (0)1 41 37 41 37 investisseurs@neurones.net |
Attachment
![](https://ml-eu.globenewswire.com/media/MzU2M2NkY2UtNDUwMi00YjgxLThmNGQtYzQ2YzM2Y2E2YTcwLTEwMTEyODQ=/tiny/NEURONES.png)
Ausgewählte Hebelprodukte auf NeuronesAct.
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf NeuronesAct.
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu NeuronesAct.
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Analysen zu NeuronesAct.
Keine Analysen gefunden.